56 days ago
Ed from Islington and others are unsettled by Companies House Filings from Skinbiotherapeutics (SBTX). Once again, in terms of transparency and governance Stuart Ashman seems determined to score another own goal.
73 days ago
I am not saying that Stuart Ashman has goofed operationally. But in terms of being transparent with investors he really is clueless and I say that in a spirit of Christian compassion.
86 days ago
Very ostentatiously the bearded Poltroon, Stuart Ashman of Skinbiotherapeutics (SBTX) and his, now thankfully departed, CFO Manprick took a 20% pay cut in early 2024 backdated to January 1 of that year. They did so as targets had been missed and more shares had needed to be issued. As Call Me Dave used to, mendaciously, comment “We are all in it together.”
86 days ago
The pretext for the June 16 placing by Skinbiotherapeutics (SBTX) conducted before the company ‘fessed that it was going to miss June 30 revenue forecasts by a country mile, was that cash was needed for a new product launch with Superdrug.
106 days ago
A helpful reader supplies a video of a man that certain commentators, habitually resident a long way up a Tyneside rectum, say that I really should respect and not refer to as the bearded, troughing, useless Geordie poltroon. That is to say Skinbiotherapeutics (SBTX) CEO Stuart Ashman. In it he discusses the forecasts published on July 7 by Singer analyst Karl “Kevin” Keegan.
110 days ago
The emails going out to institutions and private investors alike urge folks to vote CEO Stuart Ashman off the board of Skinbiotherapeutics (SBTX) at its AGM which it likes to hold between Christmas and New Year in Tyneside to ensure minimal attendance. I am happy to say that I shall vote my shares that way. The letter reads:
113 days ago
I just cannot see how Skinbiotherapeutics (SBTX) did not lead investors up the garden path, by omission not act, ahead of the June 16 2025 placing raising £4.2 million at 17p. Heads really should roll and if Nomad Singer is too weak to act against disgraced CEO Stuart Ashman and the company I have written to both the FCA and the Oxymorons at AIM Regulation asking for an immediate enquiry.
137 days ago
I am not blaming my pal the Lemming before the sensitive little fellow complains. He has done nothing wrong and indeed everything right in reporting what the bearded and grossly overpaid Geordie poltroon Stuart Ashman at Skinbiotherapeutics (SBTX) has said to him. But surely Ashman is breaking AIM Rule 10.
141 days ago
I start with Skinbotherapeutics (SBTX) and more nonsense from Stuart Ashman c/o the Lemming. Then Zenith Energy (ZEN). Argentex (AGFX) and the great and the good getting off lightly, Technology Minerals (TM1), AFC Energy (AFC), Genflow Biosciences (GENF) and a call to snap up one of the last 12 seats for ShareStock HERE UPDATE I refer to Zephyr in recording I mean Zenith! I am going senile.
149 days ago
The Singer’s initiation note on its corporate client Skinbotherapeutics(SBTX) is a curious piece of fish. For staters Singer’s makes it clear that it will not, under any circumstances, be made available to private investors it is for II’s and City HNWIs only. This is pointless.
151 days ago
This will count as an extra 11th article for the reader who does not want to read about Optibiotix (OPTI) or Skinbiotheraputics (SBTX)again.
158 days ago
I start off with Warwick School paedophile teachers, the failure of the CPS, how Warwick covered it up so causing boys elsewhere to be abused and one nonce in particular Alan Wilkins. For it was he who introduced me to the idea of a balloon debate. The main point of this bearcast is discussing today's news from Skinbiotherapeutics (SBTX) and Optibiotix (OPTI)
158 days ago
The bearded Geordie poltroon wonders why shares in Skinbiotherapeutics (SBTX)( languish at just over 16p. One major reason is that he keeps on being shown to be a liar and folks do not rush out to buy shares in companies that are run by liars. I have already shown him telling porkies about not needing a placing only to do a placing HERE. Now today we have a statement on Croda (CRDA).
171 days ago
Today Skinbiotherapeutics (SBTX) has announced that Superdrug is to sell its acne and psoriasis products. That is the good news. But to fund the rollout it has diluted us all by another 10% with a placing. On 16 April CEO Stuart Ashman recorded an Investor Meet video. Here are two clips. Please can anyone explain why he is not now exposed as a 100% lying scumbag?
176 days ago
177 days ago
197 days ago
It is no secret that I am not the biggest fan of the Skinbiotherapeutics (SBTX) boss but I explain why I feel rather sorry for him today and what he should do.to get tiresome mug punters off his case.
225 days ago
Folks like the Lemming thought that Skinbiotherapeutics (SBTX) FD Manprick Randhawa was the bees knees and were jolly cross with me for rebranding him for his patent incompetence. In my view he was useless, unable to communicate with serious investors or to stop Stuart Ashman abusing the word accretive and, at least, partially responsible for the cack handed and dilutive financing of two acquisitions. He was unable to control costs. Well, today, he has gone to pursue other business interests. Great news.. It has prompted me to buy more shares, increasing my holding by 25%.
232 days ago
I am not normally one to praise Stuart Ashman the CEO and Manprick the grossly overpaid CFO at Skinbiotherapeutics (SBTX) but yesterday’s investor meet presentation and Q&A was a very good showing by them both, especially Ashman. There I have said it. My key takeaways are:
240 days ago
241 days ago
256 days ago
282 days ago
355 days ago
The only Geordie I wish to see on video is called Cheryl. Sadly, she is not the boss at Skinbiotherapeutics (SBTX) as she’d be far less likely to arrange financings with proven fraudsters than Stuart Ashman. Anyhow Ashman and his grossly overpaid FD Manprick have recorded the video below. Notwithstanding this company’s management, I continue to regard the shares, at 16.75p, as very cheap and perfectly capable of trebling or indeed being a six bagger within 18 months. Enjoy. Or should that be, endure.
360 days ago
Skinbiotherapeutics (SBTX) is very simple. If you believe that Croda could deliver £25 million GP or anywhere close to that as CEO Stuart Ashman has intimated the shares are stupendously cheap at 17.75p. Ashman needs to do nothing apart from deliver other corporate deals and more GP from his existing IP and no more shares need be issued. Hell’s teeth why issue shares now or indeed at twice or three times the price given that on Ashman’s Croda numbers the shares could easily be 100p or even 200p! But Ashman is a git.
518 days ago
My real beef with Stuart Ashman, the CEO of Skinbiotherapeutics (SBTX) is not his grotesque pay package and the fact that he snaffled a pay rise last year when his company headed backwards operationally. Nor is it that he tells overt porkies with his “Rules are rules” claims. My real gripe is, as explained in bearcast today, how poor decisions made by him have cost we loyal shareholders badly. Losing 2/3 of the share price in less than three months is worse than careless. But back to the lying.
554 days ago
The bearded poltroon in charge of Skinbiotherapeutics (SBTX), where I remain a loyal shareholder, says that “rules are rules” and that AIM Regulation has insisted that he cannot do a video interview with me inside a paywall. That is a lie and I am now in dialogue with the Oxymorons who so far, as you can see, are evasive. For what it is worth, hapless moron Giles Balleny at Nomad Cavendish has already been shown to be lying by events elsewhere.
554 days ago
The underpants obsession is explained HERE for those not up to date on Mincemeat matters. Then it is onto gold juniors and majors the gold price, Verditek (VDTK), Supply@ME Capital (FRAUD) and a letter to AIM Regulation to call out Stuart Ashman as a liar. Rules are rules.
556 days ago
It was an hour of my time which I may look back on my deathbed and consider an hour wasted. I should say that, on balance, there was enough offered by Ashman to make me content to hold shares in Skinbiotherapeutics (SBTX) but there were also worrying matters not least the CEO telling a blatant lie.
567 days ago
In today’s podcast I discuss retirement postponed thanks to Joshua and to Stuart Ashman. I chat about Optibiotix (OPTI), en passant, but in depth about Skinbiotherapeutics (SBTX) with apologies to those who have lost money. Here is what should happen next.
598 days ago
Yesterday I exposed how Cavendish, the Nomad, to Skinbiotherapeutics (SBTX) had banned its boss Stuart Ashman from doing interviews with me as the videos would be behind a paywall. It gets worse, as a kind reader points out.
600 days ago
This is Orwellian and shows that Giles Balleny of Nomad Cavendish (formerly Finncrap & Cenkos pre merger) is either thick as pig shit or morally bankrupt or both. Given he works for Cavendish I reckon it is both. He has ordered Stuart Ashman of Skinbiotherapeutics (SBTX) to record no more videos with me.
609 days ago
In today’s bearcast I start with happy events in London last night to cheer both myself and the Euroloon Jonathan Price. Then it is on to Verditek (VDTK), Canadian Overseas (COPL), Regtech Open (FRAUD) and Supply@ME Capital (FRAUD) all four of which owe us statements. Then Kefi Gold & Copper (KEFI) and Skinbiotherapeutics (SBTX).
634 days ago
I have emailed Stuart Ashman, the boss of Skinbiotherapeutics (SBTX) this morning with, what I believe to be, a helpful suggestion.
644 days ago
I start with it being the first day of Advent and a moan about folks starting Christmas far too early. Then onto Skinbiotherapeutics (SBTX), why I am not selling and a suggestion for Stuart Ashman, a serious one, on how he can regain investor trust at a stroke. Then it is Tintra (TNT), Ceres Power (CWR), free speech on this website, Totally (TLY), Vast Resources (VAST) and Rua Life Sciences (RUA),the sponsor of today’s ouzo moment.
644 days ago
I still think Skinbiotherapeutics (SBTX) shares are cheap after results which were snuck out after hours yesterday. However, I want to flag up that for a company with sales lower than that of my local CO-OP and which spunked c£3 million in each of the last two years, the boardroom pay is obscene and just cannot be justified. The worst offender is the Sus barbatus himself, CEO Stuart Ashman.
648 days ago
I guess that while Stuart Ashman might have taken me off his Christmas card list after my recent bearcast on Skinbiotherapeutics (SBTX), Steve O’Hara at Optibiotix (OPTI) seems to agree with my analysis. We have swapped emails this morning after the publication of a TR1.
653 days ago
SkinBioTherapeutics (SBTX) has announced a placing and “retail offer” at 19p per share to raise, respectively, a minimum of £3 million and up to £0.25 million, with CEO Stuart Ashman stating this is needed “to help with the current commercialisation and development strategy of AxisBiotix in skin health, with our latest venture beginning in acne, as well as providing a stronger financial base to support our strategic partnering discussions around three of our other business pillars. The funding will also support us with working capital and strengthen our balance sheet”. Tom Winnifrith has applied for shares in the offer and we suggest you do too BUT Ashman is talking bollocks and we will be slashing our target price from 150p.
655 days ago
In this bonus Bearcast, I explain why I am cutting my target price materially for Skinbiotherapeutics (SBTX) but still see this as a potential five bagger. I am furious with Stuart Ashman who is greedy and has not delivered. And I think the company’s broker, Cavendish, has a lot of questions to answer. I warn you that Matthew’s Dog and Catriona will love this podcast.
660 days ago
I have been involved with the stockmarket for 33 years. I have done almost every job going: analyst, CEO, fund manager – crap one – even, don’t laugh, compliance officer so I get really fucked off when folks lecture me about what the rules are, especially when they clearly don’t know them themselves. I really do not like being patronized and that brings me to Stuart Ashman and Skinbiotherapeutics (SBTX) where I am, of course, a loyal shareholder.
815 days ago
Apologies for the introduction, long covid. In today’s podcast I discuss why what Gary or I say about a given stock does not matter, in the long run what matters is cash generation or lack of it. I discuss what Stuart Ashman and Steve O’Hara said about Gary’s bear piece yesterday. I discuss house prices. And I flag up that there are now just 12 tickets left for Sharestock so if you want to come book now HERE
848 days ago
I am back with these bonus video shows. I am still re-adjusting myself to Zoom so if my face looks a bit funny in part 4 there is a reason. In this show I interview Stuart Ashman of Skinbiotherapeutics (SBTX), dissect that interview myself and then ask if Oacdo (OCDO) really is the Number 1 FTSE 100 short or one for the bears to dodge. I hope you enjoy the show.
892 days ago
I am told by at least one reader that a 1 million shares sale in Skinbiotherapeutics (SBTX) MUST be Optibiotix (OPTI). The bulletin boards are full of ill-informed speculation. I am in a good mood today because West Ham are Massive so I shall not label such folks morons. Okay I will. They are morons. I have swapped emails with both Steve O’Hara of Optibiotix and Stuart Ashman of Skins.
1063 days ago
I do not always agree with Mr Lemming Investor but for what it is worth we are both still bulls of Skinbiotherapeutics (SBTX). He posted this Q&A with Stuart Ashman the other day and it is worth a read. Over to the Lemming:
1064 days ago
SkinBioTherapeutics (SBTX) has announced no-one watching o’clock (4:30pm) results for its year ended 30th June 2022, with CEO Stuart Ashman stating “this financial year has been a mixed one for the group”. With the results coming with a potentially £3.5 million equity raise (albeit including an up to £1 million “retail offer”) at 16p per share, we’ve got some other words for it but where does this all leave the company now?
1175 days ago
Let us be clear. When I said that Staurt Ashman said that month on month sales doubled in both July and August I said so because the bearded loon said so in an email to me. For him to backtrack as he does in this interview and suggest that “Mr Angry” is a bit confused, therefore makes me a bit more er….angry. If you have an hour of your life to spare, enjoy.
1189 days ago
In today’s bearcast I look in detail at Cake Box (CBOX), nanosynth (NNN) and Skinbiotherapeutics (SBTX).
1278 days ago
I discuss both these corporates, and remind the 94% of you yet to support Rogue Bloggers for Woodlarks: please do so, HERE. Then, I discuss Stuart Ashman of Skinbiotherapitics (SBTX), who has made me look like a complete git (again), as he withdraws from ShareStock. But, I will announce another BIG-name speaker tomorrow, and will replace Stuart. So, make sure you book your tickets, HERE. Then, I look at Cellular Goods (CBX) and Guild ESports (GILD), the David Beckham dogs.
1345 days ago
I start with Mello Events, which last night exposed itself as a PR promoter, failing to allow any questions about the elephant in the room: musicMagpie(MMAG). Then to Optibiotix (OPTI) and Skinbiotherapeutics (SBTX), after today’s news from the latter. I have spoken to both Steve O’Hara and Stuart Ashman. As Les points out in the comments section, the silver lining for you is the postponement of my retirement – but not for long. The market has over-reacted: long-term, these two companies will subsidise the goat farm, as I explain in detail.
1384 days ago
As you know I am reviewing my pension as discussed HERE. As such I am chatting to various CEOs who I have backed and yesterday evening I had a long chat with Stuart Ashman of Skinbiotherapeutics (SBTX). He is not a bluffing promoter but, I believe, a sober and grounded chap. I came away from the call just incredibly excited. I explain why the share price is where it is but also why this could within a couple of years be a 10 bagger but it could equally be a 20 bagger. Certainly any free cash within my SIPP will, even at twice today’s price be going into this stock. And if I am right there is a clear implication for Optibiotix (OPTI) so I am not selling any shares in it either. Footnote/correction. There are not 2 million psoriasis sufferers worldwide as per podcast but 120 million. I can’t say that weakens the case!
1451 days ago
In today’s podcast I discuss why I worry that my wife may have become a real housewife of posh Cheshire, not the part where they play rugby league. Then I look at ADM Energy (ADME) and that RNS reach issue again, tell you about a psychic moron who owns shares in Supply@ME Capital (SYME) and then I discuss, at length, Skinbiotherapeutics (SBTX) after a chat with CEO Stuart Ashman today and on the back of that I have bought more shares in the company.
1479 days ago
As predicted HERE the print going through late on Friday was Optibiotix (OPTI) dumping £2 million worth of Skinbiotherapeutics (SBTX) at 55p. I told you that this would happpen weeks ago producing more bluster and fake denials from all involved. Fuckers! The release this morning insults the intelligence of we loyal shareholders in both companies yet again. Stuart, Steve, posh PR bird Melanie Toyne-Sewell and the scumbags at Cenkos do you think we are idiots? You treat us as if we are.
1783 days ago
And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Staurt Ashman of Skinbiotherapeutics (SBTX) where I am 130% up in seven months but think the shares could 20 bag from here and bear raider Lucian Miers on macro economics his cooling feelings on cold and warming feelings on bitcoin and his big longs and shorts. Then there are a few thoughts on companies you must NOT own, including the latest nonsense from the scallywags at Powerhouse Energy (PHE).You can access the show HERE
1873 days ago
Skinbiotherapeutics (SBTX) boss Stuart Ashman until today held zero shares in the company. And he told us all that it had enough cash to last it until the end of next year at least. And so now there is a £4 million placing and £500,000 open offer at 16p. Mr Ashman can you see why I might be annoyed?
1990 days ago
And now from Wales, by just 30 yards, it is my new, I hope, weekly show. This costs 99p per episode, and you can either listen or watch very sparky interviews with our in-house gold guru Nigel Somerville on why you must be in gold and on the stocks or ETFs to own to maximise your bull market gains and with Union Jack Oil (UJO) boss David Bramhill, the most underpaid oil CEO on AIM. I also serve up a red flag-spotting session with reference to Diversified Gas & Oil (DGOC). You can access the show HERE
